The Valley Desk

NCT00680017 · Interventional trial

30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease

Overall registry status Completed

Phase 3

Conditions Dyslipidemia, Kidney Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov